Ford Robert B

Ford (CEO) buys 18.8K ABT shares at $107.13; holdings rise to 216.2K amid 22.4% decline from 52-week high

Robert B. Ford, Abbott's Chairman and CEO, purchased 18,800 shares at $107.13 on 2026-01-23, increasing his stake to 216,203 shares. The purchase occurs while the stock is -22.4% from its 52-week high and has declined 12.9% over the prior 30 days and 14.1% over 90 days. Historically, Ford's prior open-market trades across all tickers show a 90-day well-timed rate of 66.67% on 3 prior sells; his same-ticker history at ABT spans 3 prior transactions (all sales), with 2 of 3 exhibiting negative 90-day returns. The timing context—a material price decline from recent peaks—and the magnitude (+9.5% increase to his ABT holdings) merit investor attention, though the fundamental context shows reasonable metrics: Abbott's P/E of 13.53 and recent quarterly net income of $1,644,000,000 provide a baseline for evaluation.

Abbott CEO Robert Ford sells 285.4K shares (56.5% of holdings) for $37.4M at $131.17

Ford Robert B, Chairman and CEO, conducted a substantial sale of 285,388 shares on 2025-02-05 at $131.17, reducing his holdings from 505,447 to 220,059 shares and realizing $37,435,200.12. This represents a -56.5% reduction in his post-transaction position. The sale occurred near the 52-week high ($132.06), with the transaction price only -2.3% below the annual peak. His cross-ticker track record shows 2 prior sells with a 90-day well-timed rate of 100.00%, indicating his past sales preceded stock declines; at Abbott specifically, both prior sales in September 2024 were also well-timed at the 90-day mark, with the stock falling -1.6% and -2.4% after those trades. The current stock price of $129.07 is -1.6% below the transaction price, and ABT has gained +13.0% over 30 days and +10.7% over 90 days, extending its strength into 2025. The company faces headwinds with annual revenue growth declining -8.1% year-over-year, a P/E of 38.88, and most recent quarterly net income of $1,646,000,000 against revenue of $10,635,000,000. A CEO's sale of over half his holdings near the year-high, coupled with his consistent pattern of well-timed exits at this ticker, warrants investor attention to whether this signals conviction about near-term valuation or reflects portfolio rebalancing at an elevated price point.

Abbott CEO Ford sells 141,679 shares for $16.5M at $116.41, reducing stake by 39.2% to 220,059 shares

Ford Robert B, Chairman and CEO of Abbott Laboratories, executed 2 separate sales totaling 141,679 shares for $16,493,217.96 at a blended average price of $116.41 on 2024-09-12. This represents a substantial 39.2% reduction in his holdings, from 361,738 shares to 220,059 shares. The sale occurred when the stock was trading near its 52-week high of $120.96 (only 3.8% below peak), amid a strong 12.3% appreciation over the prior 90 days and positive 5.9% momentum over 30 days. The company's trailing metrics show a high P/E of 36.49 against -8.1% annual revenue growth, indicating elevated valuation in a period of revenue contraction. The scale and timing of this reduction by the CEO warrant attention as a potential signal about capital allocation priorities and conviction relative to current market valuations.